Natco Pharma Ltd. Investor Presentation

Natco Pharma Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Natco Pharma Ltd.
09 Aug 2018, 04:55PM
849.90
1.03%
pdf
logo
Natco Pharma Ltd.
26 May 2018
849.90
1.03%
pdf
logo
Natco Pharma Ltd.
07 Feb 2018
849.90
1.03%
pdf
logo
Natco Pharma Ltd.
04 Nov 2017
849.90
1.03%
pdf
logo
Natco Pharma Ltd.
14 Aug 2017
849.90
1.03%
pdf
logo
Natco Pharma Ltd.
16 Feb 2017
849.90
1.03%
Investor Presentation
BSE India
Natco Pharma Ltd has submitted to BSE a copy of Investor Presentation for the quarter ended December 31, 2016.
pdf
logo
Natco Pharma Ltd.
22 Nov 2016
849.90
1.03%
pdf
logo
Natco Pharma Ltd.
16 Sep 2016
849.90
1.03%
Presentation made to analysts /Investors
BSE India
Natco Pharma Ltd has submitted to BSE a copy of Presentation made to analysts /Investors for the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2016.
pdf
logo
Natco Pharma Ltd.
03 Jun 2016
849.90
1.03%
Presentation made to analysts / Investors
BSE India
Natco Pharma Ltd has submitted to BSE a copy of the presentation made to analysts /Investors on Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2016.
pdf
logo
Natco Pharma Ltd.
26 Feb 2016
849.90
1.03%
Presentation made to analysts / Investors
BSE India
Natco Pharma Ltd has submitted to BSE a copy of Presentation made to analysts /Investors on un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2015.
pdf